Swiss National Bank Accelerate Diagnostics, Inc Transaction History

Swiss National Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.54 - $1.41 $46,062 - $120,273	-85,300 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$1.4 - $5.15 $19,040 - $70,040	13,600 Added 18.97%	85,300 $123,000
Q1 2021 May 07, 2021	BUY	$7.99 - $15.0 $24,769 - $46,500	3,100 Added 4.52%	71,700 $597,000
Q2 2020 Aug 05, 2020	BUY	$7.49 - $15.16 $77,147 - $156,148	10,300 Added 17.67%	68,600 $1.04 Million
Q1 2020 May 08, 2020	BUY	$4.62 - $18.74 $4,158 - $16,866	900 Added 1.57%	58,300 $486,000
Q4 2019 Feb 06, 2020	BUY	$14.6 - $18.13 $27,740 - $34,447	1,900 Added 3.42%	57,400 $970,000
Q2 2019 Aug 02, 2019	SELL	$17.79 - $22.88 $67,602 - $86,944	-3,800 Reduced 6.41%	55,500 $1.27 Million
Q1 2019 May 10, 2019	BUY	$11.76 - $22.15 $17,640 - $33,225	1,500 Added 2.6%	59,300 $1.25 Million
Q1 2018 May 04, 2018	BUY	$22.55 - $29.9 $42,845 - $56,810	1,900 Added 3.4%	57,800 $1.32 Million
Q3 2017 Nov 03, 2017	BUY	$21.1 - $25.15 $1.18 Million - $1.41 Million	55,900	55,900 $1.26 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.